S J Enna. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Brain/metabolismBrain/pathologyCarnosine/metabolismCholine O-Acetyltransferase/metabolismCholinergic Fibers/physiopathologyGlutamate Decarboxylase/metabolismHumansHuntington Disease/pathologyHuntington Disease/physiopathologyHuntington Disease/therapyMental Disorders/physiopathologyMovementNerve DegenerationNorepinephrine/metabolismPeptidyl-Dipeptidase A/metabolismPhysostigmine/therapeutic useReceptors, Muscarinic/metabolismReceptors, Neurotransmitter/metabolismSerotonin/metabolismTranquilizing Agents/therapeutic usegamma-Aminobutyric Acid/analogs & derivativesgamma-Aminobutyric Acid/metabolismgamma-Aminobutyric Acid/therapeutic use
Substances: See more » Receptors, MuscarinicReceptors, NeurotransmitterTranquilizing AgentsSerotoningamma-Aminobutyric AcidCarnosinePhysostigmineCholine O-AcetyltransferasePeptidyl-Dipeptidase AGlutamate DecarboxylaseNorepinephrine
Year: 1977 PMID: 190505 DOI: 10.1016/0024-3205(77)90314-9
Source DB: PubMed Journal: Life Sci ISSN: 0024-3205 Impact factor: 5.037